Construction of Rare Disease Data Registry of Japan for autoimmune disease, and long-term nationwide multi-institutional researches utilizing the registry

Not Applicable

Recruiting

• Conditions: s disease; Systemic lupus erythematosus Antiphospholipid syndrome Polymyositis / Dermatomyositis Mixed connective tissue disease Sjogren' s syndrome Juvenile idiopathic arthritis Adult Still&#39

• Registration Number: JPRN-UMIN000043071
• Lead Sponsor: Ministry of Health, Labour and Welfare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-15
• Last Update Posted: 17 October 2023
• Study Completion: 2031-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 168

Inclusion Criteria

Not provided

Exclusion Criteria

Patients judged to be inappropriate as a target by the judgment of researchers.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
death and relapse during 10 years

Secondary Outcome Measures

Name	Time	Method
ung, renal, cardiovascular, pulmonary artery, neurological, and skin lesions due to underlying autoimmune diseases. Macrophage activation syndrome. Adverse events(malignancy, infection requiring hospitalization, cardio-cerebrovascular diseases, bone fracture, drug eruption). Severity and disease activity of underlying autoimmune diseases. Patient-reported outcome. EQ-5D-5L.